EUVIMEDEUVIMED entdecken
Crossref

The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death

Esther L Jones Evans iD, Benjamin Demarco iD, Han Cai iD, Madelon M E de Jong iD, Sarah Hill iD, Marcus A Widdess iD, Joannah R Fergusson iD, Ryan E Glass iD, Gemma Harris iD, Gracie J Mead iD, Yavuz F Yazicioglu iD, Saba Nayar iD und 6 weitere

Science Immunology · 2026

DOI: 10.1126/sciimmunol.ads9680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, 2026. Verfasst von Esther L Jones Evans und 17 weiteren Autor:innen. Beteiligte Einrichtung: Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Ribonucleoproteins, Autoantigens, Antigen-Antibody Complex, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 96 Literaturangaben. Gefördert von: Wellcome, Kennedy Trust for Rheumatology Research, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sjögren’s disease (SjD) causes localized and systemic inflammation and autoantibody production against intracellular proteins such as TRIM21/Ro52 (tripartite motif-containing protein 21). TRIM21, an E3 ubiquitin ligase, binds antibody Fc domains on opsonized pathogens that have escaped extracellular immunity and entered the cytosol. TRIM21 then ubiquitinates these pathogens, driving their proteasomal degradation. How TRIM21 becomes an autoantigen remains unclear. We show that TRIM21 is released upon lytic cell death (pyroptosis or necroptosis) but not apoptosis. Although many cytosolic proteins are released by dead cells, liberated TRIM21 is distinct: Its high antibody affinity enables binding to Fc domains of circulating immunoglobulins, forming large immune complexes (ICs). These ICs increase in SjD, where anti-TRIM21 autoantibodies interact with released TRIM21 via Fc and F(ab′) 2 . TRIM21 ICs are taken up by macrophages, which drive proinflammatory responses, antigen presentation, and metabolic changes in high interferon environments. Thus, TRIM21 may perpetuate inflammation and autoantigen presentation, resulting in high immunogenicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RibonucleoproteinsAutoantigensAntigen-Antibody ComplexInflammationHumansTRIM21 ProteinSS-A AntigenCell DeathAnimalsMacrophagesAutoantibodies

Substanzen

RibonucleoproteinsTRIM21 ProteinAutoantigensAntigen-Antibody ComplexSS-A AntigenAutoantibodies

Autor:innen und Institutionen

  • Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Quest Diagnostics, Chantilly, VA, USA.
  • Research Complex at Harwell, Didcot, UK.
  • School of Infection, Inflammation and Immunology, University of Birmingham, Birmingham, UK.
  • National Institute of Health Research (NIHR) Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

ORCID-Profile: Esther L Jones Evans, Benjamin Demarco, Han Cai, Madelon M E de Jong, Sarah Hill, Marcus A Widdess, Joannah R Fergusson, Ryan E Glass, Gemma Harris, Gracie J Mead, Yavuz F Yazicioglu, Saba Nayar, Benjamin A Fisher, Mark S Cragg, Alexander J Clarke, Audrey Gérard, Jelena S Bezbradica, Lynn B Dustin

Förderung

  • Wellcome
  • Kennedy Trust for Rheumatology Research
  • Medical Research Council
  • Henni Mester Fellowship, University College, University of Oxford
  • Oxford-Bristol Myers Squibb Celgene Research Fellowship Programme
  • Medical Research Council UK
  • Birmingham Biomedical Research Centre
  • National Institute for Health Research

Zitieren

APA

Jones Evans, E. L., Demarco, B., Cai, H., de Jong, M. M. E., Hill, S., Widdess, M. A., Fergusson, J. R., Glass, R. E., Harris, G., Mead, G. J., Yazicioglu, Y. F., Nayar, S., Fisher, B. A., Cragg, M. S., Clarke, A. J., Gérard, A., Bezbradica, J. S., & Dustin, L. B. (2026). The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death. Science Immunology. https://doi.org/10.1126/sciimmunol.ads9680

Vancouver

Jones Evans EL, Demarco B, Cai H, de Jong MME, Hill S, Widdess MA, et al. The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death. Science Immunology. 2026. doi:10.1126/sciimmunol.ads9680

BibTeX
@article{JonesEvans2026,
  author = {Jones Evans, Esther L and Demarco, Benjamin and Cai, Han and de Jong, Madelon M E and Hill, Sarah and Widdess, Marcus A and Fergusson, Joannah R and Glass, Ryan E and Harris, Gemma and Mead, Gracie J and Yazicioglu, Yavuz F and Nayar, Saba and Fisher, Benjamin A and Cragg, Mark S and Clarke, Alexander J and Gérard, Audrey and Bezbradica, Jelena S and Dustin, Lynn B},
  title = {The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death},
  journal = {Science Immunology},
  year = {2026},
  doi = {10.1126/sciimmunol.ads9680}
}
Kostenlos starten →